We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Charity Commission offers advice to all charities as it closes its case into the Actors’ Benevolent Fund.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
How we engage and involve patients and the public in our regulatory decision-making.
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
Information to support your recovery after COVID-19.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
The characteristics, diagnosis, management, surveillance and epidemiology of CJD.
A development programme of educational resources on critical public health topics for people who work in the health and care sector and the extended public health workforce.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Actions that trial sponsors should consider to build resilience into clinical trial design
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Find out about the long-term effects some people can have after having COVID-19.
Principles to support decision making for those involved in safely planning and protecting visiting during outbreaks of infectious illness in adult social care.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
NCARDRS records those people with congenital abnormalities and rare diseases across the whole of England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).